Tomoro Hishiki
Overview
Explore the profile of Tomoro Hishiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishimura K, Aoki T, Kobayashi M, Takami M, Ozaki K, Ogawa K, et al.
Cancer Sci
. 2025 Feb;
PMID: 39916425
While antibody-dependent cellular cytotoxicity (ADCC) by anti-disialoganglioside GD2 monoclonal antibody (mAb) has succeeded in increasing the survival rate of high-risk patients with neuroblastoma, approximately 40%-50% of patients die from the...
2.
Takenouchi A, Terui K, Komatsu S, Oita S, Kawaguchi Y, Nishimura K, et al.
Pediatr Int
. 2025 Jan;
67(1):e15874.
PMID: 39840690
No abstract available.
3.
Katsumata Y, Terui K, Takenouchi A, Komatsu S, Kawaguchi Y, Nishimura K, et al.
J Pediatr Surg
. 2024 Dec;
60(2):162076.
PMID: 39637481
Background: This study aimed to develop a prediction model for intestinal perforation from meconium ileus (MI) based on findings from plain X-ray images. Methods: Very low birth weight (VLBW) infants...
4.
Demir S, Hotes A, Schmid T, Cairo S, Indersie E, Pisano C, et al.
J Exp Clin Cancer Res
. 2024 Nov;
43(1):299.
PMID: 39529166
Background: Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still compromises patient outcomes making...
5.
Hiyama E, Hishiki T, Yoshimura K, Krailo M, Maibach R, Haeberle B, et al.
EClinicalMedicine
. 2024 Sep;
76:102811.
PMID: 39309724
Background: In the treatment of resectable hepatoblastoma (HB), it has not been established whether upfront surgery (UF) at diagnosis or neoadjuvant chemotherapy and delayed surgery (DL) is preferred. We compared...
6.
Kudo W, Terui K, Furugane R, Takenouchi A, Komatsu S, Kawaguchi Y, et al.
Pediatr Surg Int
. 2024 Aug;
40(1):237.
PMID: 39164514
Purpose: To elucidate the clinical significance of sarcopenia in children with neuroblastic tumors (NTs). Methods: We conducted a retrospective observational study and analyzed the z-scores for height, body weight, body...
7.
Nishimura K, Takenouchi A, Komatsu S, Kawaguchi Y, Kudo W, Takiguchi S, et al.
Pediatr Surg Int
. 2024 Aug;
40(1):234.
PMID: 39158590
Purpose: This study aimed to investigate the impact of nephrostomies on the outcome of total renal function (TRF) and split renal function (SRF) in patients with malignant pelvic tumors associated...
8.
Saeki I, Ida K, Kurihara S, Watanabe K, Mori M, Hishiki T, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(11):e31255.
PMID: 39126361
Background: The JPLT3-S (Japanese Study Group for Pediatric Liver Tumors-3) study, conducted cisplatin (CDDP) monotherapy for young children (<3 years old) with standard-risk hepatoblastoma (HB) using a central review system...
9.
Komatsu S, Terui K, Takenouchi A, Kawaguchi Y, Nishimura K, Oita S, et al.
Surg Today
. 2024 Jul;
55(3):386-392.
PMID: 39085699
Purpose: This pilot study evaluated indocyanine green-guided near-infrared fluorescence (ICG-NIRF) imaging of testicular blood flow to predict long-term testicular atrophy after testicular torsion (TT) surgery. Methods: The subjects of this...
10.
Riehle K, Vasudevan S, Bondoc A, Cuenca A, Garnier H, Kastenberg Z, et al.
Pediatr Blood Cancer
. 2024 Jul;
:e31155.
PMID: 38953150
Two percent of pediatric malignancies arise primarily in the liver; roughly 60% of these cancers are hepatoblastoma (HB). Despite the rarity of these cases, international collaborative efforts have led to...